Blog
February 13, 2026
Hard reality: experienced investors can tell—often within minutes—when regulatory strategy was bolted on late instead of built in early. You don’t need to say “we figured […]
February 12, 2026
Simple truth: small regulatory misalignments early in development don’t stay small. They compound—quietly at first, then catastrophically—into six- and seven-figure problems later. Most medical device cost […]
February 11, 2026
Yes—absolutely.In fact, regulatory strategy is most powerful before a physical prototype exists. At the earliest stage, regulatory thinking acts as a design compass. It tells you […]
February 10, 2026
When regulatory strategy starts after prototyping, things don’t just slow down—they break. And once they break, they are expensive to fix. Medical device development is not […]
